Intravesical BCG therapy after transurethral resection of bladder tumor (TURB) is considered the most effective treatment for prophylaxis against the recurrence of high risk non-muscle invasive bladder cancer, and generally well tolerated and infectious complication are rare. We reported a case of granulomatous prostatitis is a patient who had undergone intravesical BCG therapy due to non-invas...

Objective: To determine the correlation between intravesical prostatic protrusion and maximum flow rate in benign hyperplasia among Nigerian men.
 Materials Methods: A cross-sectional prospective study that included patients who presented to Urology clinic of Jos University Teaching Hospital with clinical features BPE. Each had IPSS, Qmax IPP measured addition evaluation. Statistical analy...

Abstract: The characteristic feature of Interstitial cystitis (IC) or bladder pain syndrome is augmented, pressure, inconvenience in the suprapubic region. causative factors for IC are not completely understood however certain underlying disease condition may trigger pain. therapy aimed to provide symptomatic relief, and therefore, treatment protocols have been established based on experience. ...

OBJECTIVES To provide a brief overview of intravesical dimethly sulfoxide (DMSO) therapy for interstitial cystitis and offer a practical approach to patient treatment. METHODS A review of the literature and a summation of the experience with treatment of > 300 patients with DMSO at the Interstitial Cystitis Clinic, New England Medical Center. RESULTS DMSO is helpful in a significant number ...

Immunotherapy with Bacillus Calmette-Guérin (BCG) to treat non-muscle invasive bladder cancer has become an effective and superior alternative to chemotherapy. Intravesical treatment with BCG appears to be relatively safe; however, occasionally BCG infection complicates such treatment. In the present work we describe three patients in whom BCG infection occurred after intravesical BCG therapy. ...

Bladder pain syndrome/interstitial cystitis (BPS/IC) is a chronic pain condition characterised by urinary frequency, urgency and pain or discomfort which the patient attributes to the bladder. It is a complex condition to manage and treat and requires a multi-disciplinary and multi-modal approach. As well as lifestyle and behavioural modifications, physical therapy and oral medications, intrave...

Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is a common treatment modality for bladder cancer after transurethral resection of a bladder tumor. This therapy is generally safe, and development of a prostatic abscess with a prostatorectal fistula after intravesical BCG immunotherapy is a very rare complication. This finding was incidentally obtained by the authors, who examined a pa...

Ectopic location of Intrauterine Contraceptive Device (IUCD) or its migration from the normal position in uterine fundus is a frequently encountered complication. It varies expulsion to displacement into endometrial canal perforation intravesical migration, which an extremely rare case. Ultrasonography was used diagnoses this reported case ectopic IUCD.